SGD Pharma has reported a 27% reduction in Scope 1 [...]
At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]
Company aligns with CSRD and reports top 1% EcoVadis ranking [...]
A Yorkshire-based company is quietly transforming how pharmaceutical and clinical [...]